Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
Clinical trial NCT07753603 · RECRUITING
Trial details
- NCT number
- NCT07753603
- Sponsor
- Sling Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-04
- Primary completion
- 2028-06-30
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.